NCT05164874

Brief Summary

Organized breast cancer screening (OBCS) has been implemented nationwide since 2004 inFrance, but the participation rate remains low (51%) and inequities in participation were reported. Strategies as mobile mammography units could be effective to increase participation in OBCS and reduce inequities, especially in underserved areas in regard to this screening. Our main objective is to evaluate this device and to identify how to incorporate a mobile unit in the OBCS with a view to tackle territorial inequities in OBCS participation. The project will be conducted as a randomized controlled cluster trial in 2022-2024, in remote areas of 4 French departments. The main intervention is to propose an appointment at the mobile unit in complement to the current OBCS in these remote areas. In addition, few weeks before this intervention, local actors will carry out actions to promote OBCS with mobile unit specific information tools. This randomized controlled trial will provide a high level of evidence in assessing the mobile unit effects on participation and inequities.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
91,982

participants targeted

Target at P75+ for not_applicable breast-cancer

Timeline
Completed

Started Feb 2022

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 3, 2021

Completed
18 days until next milestone

First Posted

Study publicly available on registry

December 21, 2021

Completed
2 months until next milestone

Study Start

First participant enrolled

February 14, 2022

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2024

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2024

Completed
Last Updated

December 21, 2021

Status Verified

November 1, 2021

Enrollment Period

2 years

First QC Date

December 3, 2021

Last Update Submit

December 20, 2021

Conditions

Keywords

breast cancer screeningmobile mammography unitsocial and territorial inequalitiesrandomized cluster trial

Outcome Measures

Primary Outcomes (4)

  • Aggregated breast cancer screening participation rate 3 months after the last invitation

    Participation rate will be measure at area level and compare between intervention and control arm.

    3 months after the last invitation at the end of the two years of the intervention

  • Individual breast cancer screening participation rate 3 months after the last invitation

    It will also be assessed at indivdual level with multilevel logistic regression

    3 months after the last invitation at the end of the two years of the intervention

  • Impact of the mobile unit on social inequalities in screening participation

    Impact of the mobile mammography unit on social inequalities will be assessed by comparing intervention and control arm. Social statut is measure with an ecological deprivation index

    3 months after the last invitation at the end of the two years of the intervention

  • Impact of the mobile unit on territorial inequalities in screening participation

    impact of the mobile mammography unit territorial inequalities will be assessed by comparing intervention and control arm. The distance to the radiologiste center will be used as territorial mesure

    3 months after the last invitation at the end of the two years of the intervention

Secondary Outcomes (5)

  • Informed choice to breast cancer screening for participating women

    through study completion, an average of 3 month

  • Informed choice to breast cancer screening for non-participating women

    Women will be considered as "non participating" 18 month after the invitation

  • Satisfaction to mammography

    through study completion, an average of 3 month

  • Com-B Model Evaluation for participating women

    through study completion, an average of 3 month

  • Com-B Model Evaluation for non-participating women

    Women will be considered as "non participating" 18 month after the invitation

Study Arms (2)

Intervention

EXPERIMENTAL

Women will receive a proposition for an appointment at the MMU in complement to the current screening invitation, keeping the choice of their place of screening. Women will also receive the timetable of prevention actions with the invitation to participate in screening.

Device: Mobile Mammography Unit

Control

NO INTERVENTION

No change from the usual breast cancer screening organization

Interventions

The main intervention will be a proposition for an appointment at the MMU in complement to the current OBCS

Intervention

Eligibility Criteria

Age50 Years - 74 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • women eligible to breast cancer screening campaign : aged 50 to 74 years, and with the only risk of breast cancer being age. The previous screening mammography dating from 22 months

You may not qualify if:

  • outside the ages
  • with specific risk of breast cancer

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Normandy

Caen, Normandy, 14000, France

Location

Related Publications (1)

  • Guillaume E, Rollet Q, Launay L, Beuriot S, Dejardin O, Notari A, Crevel E, Benhammouda A, Verzaux L, Quertier MC, Launoy G. Evaluation of a mobile mammography unit: concepts and randomized cluster trial protocol of a population health intervention research to reduce breast cancer screening inequalities. Trials. 2022 Jul 8;23(1):562. doi: 10.1186/s13063-022-06480-w.

MeSH Terms

Conditions

Breast Neoplasms

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue Diseases

Study Officials

  • Elodie Guillaume, PhD

    Université de Caen Normandie

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: This intervention will be conducted as a prospective randomized controlled cluster trial.The cluster of the study is an aggregation of géographical areas. It was done according to the travel time to the radiology centres, the most distant areas has been selected and then merged with neighbouring areas, still by distance run, until reaching areas of the expected population size. This except size is around 100 women. Expecting a 40% participation to the mobile unit, we will achieve 32 to 48 mammograms daily. A randomization in parallel group have been perform to constitute the intervention arm and the control arm.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PhD in Epidemiology and Public Health

Study Record Dates

First Submitted

December 3, 2021

First Posted

December 21, 2021

Study Start

February 14, 2022

Primary Completion

February 1, 2024

Study Completion

September 1, 2024

Last Updated

December 21, 2021

Record last verified: 2021-11

Data Sharing

IPD Sharing
Will share

Individual data is collected as part of the usual organization of organized breast cancer screening. It is the authorized structure that manages these data.

Time Frame
Data concerning participation, place of participation, date, distance and socioeconomic status will be anonimously analysed after the two years.

Locations